Skip to main content
Premium Trial:

Request an Annual Quote

InforMax Appoints James Bernstein as President

NEW YORK, Dec 19 – InforMax has promoted James Bernstein, formerly chief operating officer and executive vice president of strategic development, to the position of president, the company announced Tuesday.

Bernstein will report to Alex Titomirov, InforMax’s founder, CEO, and chairman, the company said. Titomirov formerly held the title of president.

" Jim Bernstein has played a key role in the growth and development of InforMax, particularly over the past two years," Titomirov said in a statement. " It gives me great pleasure to recognize his many contributions and his increasing involvement with me in directing the company's activities."

This appointment comes just after Titomirov announced he was launching RealTime Health, a new start-up that would make gene expression-based preventive medicine technology available to individuals.

Bernstein, who became COO of InforMax in 1998, previously founded two companies, General Health, a health management risk assessment publishing company, and Age Wave, a holding company that starts aging-based businesses. Bernstein has also worked to develop a company to distribute pharmaceuticals to Russia and consulted with the National Heart, Lung and Blood Institute of the National Institutes of Health.

Bernstein is a 1960 graduate of Harvard College and a 1964 graduate of Cornell University Medical College.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.